CNP
57
3
DVA
71
5
CPB
24
2
DHR
47
-2
HD
40
2
UNP
48
5
ORCL
38
2
PEG
57
4
URI
40
7
LUV
48
3
STT
56
2
BEN
28
3
DTE
58
2
TGT
53
-3
DHI
40
5
MAR
51
4
LLY
28
-12
A
58
4
EW
30
-2
NRG
42
7
CNP
57
3
DVA
71
5
CPB
24
2
DHR
47
-2
HD
40
2
UNP
48
5
ORCL
38
2
PEG
57
4
URI
40
7
LUV
48
3
STT
56
2
BEN
28
3
DTE
58
2
TGT
53
-3
DHI
40
5
MAR
51
4
LLY
28
-12
A
58
4
EW
30
-2
NRG
42
7
Financhill
Back

Mirum Pharmaceuticals Vs. Blueprint Medicines Industry Stock Comparison

Sell
47

MIRM
Mirum Pharmaceuticals

Last Price:
$43.36
Seasonality Move:
10.4%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
47
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $43.32. The Score for MIRM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $43.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $102.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 54.28 Buy
Chaikin Money Flow: -781328 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.36 - 43.38) Buy
Bollinger Bands (100): (39.42 - 43.62) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 63.82 Buy
Chaikin Money Flow: -913925 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.06 - 96.6) Buy
Bollinger Bands (100): (86.99 - 95.95) Buy

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.58 Buy
20-day SMA: 42.07 Buy
50-day SMA: 42.83 Buy
200-day SMA: 36.12 Buy
8-day EMA: 42.62 Buy
20-day EMA: 42.49 Buy
50-day EMA: 42.26 Buy
200-day EMA: 37.73 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 91.76 Buy
50-day SMA: 93.83 Buy
200-day SMA: 96.87 Buy
8-day EMA: 94.89 Buy
20-day EMA: 92.92 Buy
50-day EMA: 92.72 Buy
200-day EMA: 91.71 Buy

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $2.04 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):